These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


99 related items for PubMed ID: 9544206

  • 1. 2-amino-4H-3,1-benzoxazin-4-ones as inhibitors of C1r serine protease.
    Hays SJ, Caprathe BW, Gilmore JL, Amin N, Emmerling MR, Michael W, Nadimpalli R, Nath R, Raser KJ, Stafford D, Watson D, Wang K, Jaen JC.
    J Med Chem; 1998 Mar 26; 41(7):1060-7. PubMed ID: 9544206
    [Abstract] [Full Text] [Related]

  • 2. Novel thieno[2,3-d][1,3]oxazin-4-ones as inhibitors of human leukocyte elastase.
    Gütschow M, Neumann U.
    J Med Chem; 1998 May 07; 41(10):1729-40. PubMed ID: 9572899
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Studies on 2-benzyloxy-4H-3,1-benzoxazin-4-ones as serine protease inhibitors.
    Gütschow M, Neumann U, Sieler J, Eger K.
    Pharm Acta Helv; 1998 Jul 07; 73(2):95-103. PubMed ID: 9700938
    [Abstract] [Full Text] [Related]

  • 5. Benzenesulfonamide derivatives of 2-substituted 4H-3,1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease.
    Plummer JS, Cai C, Hays SJ, Gilmore JL, Emmerling MR, Michael W, Narasimhan LS, Watson MD, Wang K, Nath R, Evans LM, Jaen JC.
    Bioorg Med Chem Lett; 1999 Mar 22; 9(6):815-20. PubMed ID: 10206542
    [Abstract] [Full Text] [Related]

  • 6. Rational design, synthesis, and biological activity of benzoxazinones as novel factor Xa inhibitors.
    Dudley DA, Bunker AM, Chi L, Cody WL, Holland DR, Ignasiak DP, Janiczek-Dolphin N, McClanahan TB, Mertz TE, Narasimhan LS, Rapundalo ST, Trautschold JA, Van Huis CA, Edmunds JJ.
    J Med Chem; 2000 Nov 02; 43(22):4063-70. PubMed ID: 11063603
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Benzoxazin-4-ones as novel, easily accessible inhibitors for rhomboid proteases.
    Yang J, Barniol-Xicota M, Nguyen MTN, Ticha A, Strisovsky K, Verhelst SHL.
    Bioorg Med Chem Lett; 2018 May 01; 28(8):1423-1427. PubMed ID: 29506958
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Novel potent and selective thrombin inhibitors based on a central 1,4-benzoxazin-3(4H)-one scaffold.
    Ilas J, Tomasić T, Kikelj D.
    J Med Chem; 2008 May 08; 51(9):2863-7. PubMed ID: 18412326
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
    Bajusz S, Fauszt I, Németh K, Barabás E, Juhász A, Patthy M, Bauer PI.
    Biopolymers; 1999 May 08; 51(1):109-18. PubMed ID: 10380358
    [Abstract] [Full Text] [Related]

  • 16. Substituted isocoumarins as inhibitors of complement serine proteases.
    Kam CM, Oglesby TJ, Pangburn MK, Volanakis JE, Powers JC.
    J Immunol; 1992 Jul 01; 149(1):163-8. PubMed ID: 1607651
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.